RE:RE:RE:RE:Valuable information✍Most are forgetting to take into account for the Tilray Medical facilities in Germany and their likely increase in medical cannabis sales.
The company has realeased a ton of new products over the last year and, in all likelihood, those products will pull in increased revenue for the business.
Zacks jacked up their rating and are projectng $225 million on this report. Total for the year will still likely be under 1 Billion in total revenue however that is significant compared to the competition.
Looking forward to the US entry plan being presented and that too will involve interest from the market.
Hang in there Kitty